Skip to main content

Development of broadly neutralizing antibodies to influenza

Development of broadly neutralizing antibodies to influenza using a novel bacterial outer membrane vesicle platform:
The Leifer and Putnam labs have an ongoing collaboration to use innovative engineering techniques develop, test, and understand the underlying immunological mechanisms of new vaccine adjuvant bacterial outer membrane vesicle platforms. We are interested in postdoctoral candidates proposing to take a cross-disciplinary approach to vaccine and adjuvant development, and animal model testing. The collaboration between the Putnam and Leifer labs is supported by a recently awarded NIH R01, but the candidate can propose related projects that take advantage of the expertise in both labs. Experience in the following techniques is preferred, but not required: microbiology, molecular biology, small animal models, and immune response assays.

This project is a collaboration between the Cynthia Leifer, and David Putnam labs.